Ca. Mclean et al., COMMENTARY ON THE CONSENSUS RECOMMENDATIONS FOR THE POST-MORTEM DIAGNOSIS OF ALZHEIMERS-DISEASE, Neurobiology of aging, 18(4), 1997, pp. 89-90
The consensus recommendations for the post mortem diagnosis Alzheimer'
s disease (AD) highlight the difficulties in establishing a pathologic
al diagnosis in brains from clinically demented individuals with both
certainty and uniformity. There is, however, a need fur diagnostic gui
delines that are relatively simple, inexpensive, and adaptable to gene
ral pathologists and different laboratories. The current Consortium to
Establish a Registry for Alzheimer's disease (CERAD) criteria and the
recommendations in the consensus document giving three probabilistic
categories for diagnosis go a long way towards establishing a uniform
approach for the diagnosis of AD. However, more uniformity could be ad
opted in;he topography of sectioning to enhance diagnostic and future
research comparisons. We also recommend that immunohistochemistry for
beta A4 (A beta) amyloid and tau-reactive neurofibrillary changes, in
addition to hematoxylin and eosin stains, should become the basis for
histological diagnosis. We agree with the guidelines concerning docume
ntation of all AD changes. Until a clearer understanding of the early
changes of AD is established, strict observation and recording are the
pathologists' best diagnostic skills. The ill-defined diagnostic area
s of AD continue to prompt the need for a new method of detection of t
he underlying pathologic process. (C) 1997 Elsevier Science Inc.